Rekha Garg

3.6k total citations · 2 hit papers
42 papers, 2.5k citations indexed

About

Rekha Garg is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Epidemiology. According to data from OpenAlex, Rekha Garg has authored 42 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cardiology and Cardiovascular Medicine, 10 papers in Surgery and 8 papers in Epidemiology. Recurrent topics in Rekha Garg's work include Heart Failure Treatment and Management (14 papers), Parathyroid Disorders and Treatments (7 papers) and Cardiovascular Function and Risk Factors (7 papers). Rekha Garg is often cited by papers focused on Heart Failure Treatment and Management (14 papers), Parathyroid Disorders and Treatments (7 papers) and Cardiovascular Function and Risk Factors (7 papers). Rekha Garg collaborates with scholars based in United States, Canada and Germany. Rekha Garg's co-authors include Salim Yusuf, Pierre‐François Laterre, Howard Levy, Benjamin Trzaskoma, William L. Macias, Barbara G. Utterback, Álvaro Réa-Neto, Bertram Pitt, Edward Abraham and Bruno François and has published in prestigious journals such as New England Journal of Medicine, JAMA and Circulation.

In The Last Decade

Rekha Garg

41 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Overview of Randomized Trials of Angiotensin-Converting Enzyme Inhibitors on Mortality and Morbidity in Patients With Heart Failure

1995 1.0k citations Rekha Garg profile →
Drotrecogin Alfa (Activated) for Adults with Severe Sepsis and a Low Risk of Death

2005 567 citations Edward Abraham, Pierre‐François Laterre et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Rekha Garg

Since Specialization

Citations

This map shows the geographic impact of Rekha Garg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rekha Garg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rekha Garg more than expected).

Fields of papers citing papers by Rekha Garg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rekha Garg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rekha Garg. The network helps show where Rekha Garg may publish in the future.

Co-authorship network of co-authors of Rekha Garg

This figure shows the co-authorship network connecting the top 25 collaborators of Rekha Garg. A scholar is included among the top collaborators of Rekha Garg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rekha Garg. Rekha Garg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A novel assay to measure calcification propensity: from laboratory to humans 2020 ·Scientific Reports ·(unknown), Miguel D. Ferrer, (unknown), A. Canals, Elisenda Bañón-Maneus, Josep M. Campistol, (unknown), Rekha Garg, Alex Gold, Carolina Salcedo, Joan Perelló	6
2	Slowing Progression of Cardiovascular Calcification With SNF472 in Patients on Hemodialysis 2019 ·Circulation ·Paolo Raggi, Antonio Bellasi, David A. Bushinsky, Jordi Bover, Mariano Rodríguez, Markus Ketteler, Smeeta Sinha, Carolina Salcedo, (unknown), Claire Padgett, Rekha Garg, Alex Gold, Joan Perelló, Glenn M. Chertow	104
3	Improvement in wound healing, pain, and quality of life after 12 weeks of SNF472 treatment: a phase 2 open-label study of patients with calciphylaxis 2019 ·Journal of Nephrology ·Vincent Brandenburg, Smeeta Sinha, José‐Vicente Torregrosa, Rekha Garg, (unknown), (unknown), Daun Bahr, Pieter Joubert, Carolina Salcedo, Kevin J. Carroll, Alex Gold, Joan Perelló	28
4	Use of an integrated clinical trial database to evaluate the effect of timing of drotrecogin alfa (activated) treatment in severe sepsis 2006 ·Critical Care ·Jean‐Louis Vincent, James M. O’Brien, Arthur P. Wheeler, Xavier Wittebole, Rekha Garg, Benjamin Trzaskoma, David P. Sundin	32
5	Racial differences in outcome and treatment effect in congestive heart failure 2005 ·American Heart Journal ·James Mathew, Janet Wittes, Frances McSherry, William O. Williford, Rekha Garg, Jeffrey L. Probstfield, Salim Yusuf	27
6	Drotrecogin Alfa (Activated) for Adults with Severe Sepsis and a Low Risk of Death breakdown → 2005 ·New England Journal of Medicine ·Edward Abraham, Pierre‐François Laterre, Rekha Garg, Howard Levy, Deepak Talwar, Benjamin Trzaskoma, Bruno François, Jeffrey S. Guy, Martina Brückmann, Álvaro Réa-Neto, Rolf Rossaint, D. Perrotin, Armin Sablotzki, (unknown), Barbara G. Utterback, William L. Macias	567
7	The effect of drotrecogin alfa (activated) on long-term survival after severe sepsis * 2004 ·Critical Care Medicine ·Derek C. Angus, Pierre‐François Laterre, (unknown), E. Wesley Ely, Daniel Ball, Rekha Garg, Lisa A. Weissfeld, Gordon R. Bernard	99
8	Geographic Variations in Use of Recommended Severe Sepsis Interventions Observed in PROGRESS Severe Sepsis Registry Data 2004 ·CHEST Journal ·Konrad Reinhart, Geoffrey Dobb, Jean‐Louis Vincent, Samiha Sarwat, Rekha Garg, Richard Beale	0
9	Comparison of PROGRESS Severe Sepsis Registry Patients to INDEPTH Integrated Severe Sepsis Clinical Trial Database Placebo Patients 2004 ·CHEST Journal ·Richard Beale, Konrad Reinhart, Eliezer Silva, Geoffrey Dobb, Samiha Sarwat, Rekha Garg, Jean‐Louis Vincent	2
10	The role of the data coordinating center in the IRB review and approval process: the DIG trial experience 2003 ·Controlled Clinical Trials ·Joseph F. Collins, Rekha Garg, Koon Teo, William O. Williford, (unknown), (unknown)	9
11	The use of regional coordinating centers in large clinical trials: the DIG trial 2003 ·Controlled Clinical Trials ·Joseph F. Collins, (unknown), (unknown), (unknown), Rekha Garg, Debra Egan, (unknown)	9
12	The effect of digoxin on the quality of life in patients with heart failure 2003 ·Journal of Cardiac Failure ·Ellis Lader, Debra Egan, Sally Hunsberger, Rekha Garg, Susan M. Czajkowski, Frances McSherry	33
13	Lessons learned from the DIG trial 2003 ·Controlled Clinical Trials ·Debra Egan, Nancy L. Geller, Salim Yusuf, Rekha Garg, Joseph F. Collins, James Mathew, Edward F. Philbin, (unknown)	2
14	Compliance to Multiple Interventions in a High Risk Population 1999 ·Annals of Epidemiology ·Mary Pettinger, Myron A. Waclawiw, Kathryn Davis, (unknown), Rekha Garg, (unknown), Debra Egan	10
15	Niacin treatment increases plasma homocyst(e)ine levels 1999 ·American Heart Journal ·Rekha Garg, M.R. Malinow, Mary Pettinger, Barbara Upson, Donald B. Hunninghake	40
16	Rationale and design of the arterial disease multiple intervention trial (ADMIT) pilot study 1999 ·The American Journal of Cardiology ·Debra Egan, Rekha Garg, Timothy J Wilt, Mary Pettinger, Kathryn Davis, John R. Crouse, J. Alan Herd, Donald B. Hunninghake, David S. Sheps, John B. Kostis, Jeffrey L. Probstfield, Myron A. Waclawiw, William B. Applegate, Marshall B. Elam	16
17	Current and ongoing randomized trials in heart failure and left ventricular dysfunction 1993 ·Journal of the American College of Cardiology ·Rekha Garg, Salim Yusuf	7
18	Effect of Angiotensin-Converting Enzyme Inhibitors in Left Ventricular Dysfunction 1993 ·Journal of Cardiovascular Pharmacology ·(unknown), Rekha Garg, (unknown)	3
19	Heart failure in the 1990s: Evolutions of a major public health problem in cardiovascular medicine 1993 ·Journal of the American College of Cardiology ·Rekha Garg, Milton Packer, Bertram Pitt, Salim Yusuf	138
20	Need for a large randomized trial to evaluate the effects of digitalis on morbidity and mortality in congestive heart failure 1992 ·The American Journal of Cardiology ·Salim Yusuf, Rekha Garg, Peter Held, Richard Gorlin	50

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact